Abstract
Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal chamber of the ventriculum on the hemodynamic assessment. Atrio-ventricular sequential pacing and alcohol ablation have been proposed as less invasive alternatives to surgery for patients who fail to respond to pharmacologic therapy. The present case represents successful percutaneous treatment with alcohol ablation to patient with MVOHC and apical aneurysm. Alcohol ablation to distal segment of the left anterior descending artery resulted with relief of clinical symptoms and intra-ventricular pressure gradient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
C Seidman, Hypertrophic cardiomyopathy: from man to mouse. J Clin Invest 106 (2000) 9-13
H Kuhn, J Mercier, KH Frenzel, W Hort and F Loogen, Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic nonobstructive cardiomyopathy. Eur Heart J 4 (1983) 93-104
ED Wigle and H Rakowski, Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle?. J Am Coll Cardiol 19 (1992) 525-526
DM Yoerger and AE Weyman, Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Rev Cardiovasc Med 4 (2003) 199-215
H Seggewiss, U Gleichmann, L Faber, D Fassbender, HK Schmidt and S Strick, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 31 (1998) 252-258
L Faber, H Seggewiss and U Gleichmann, Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation 98 (1998) 2415-2421
T Nakamura, K Matsubara, K Furukawa, A Azuma, H Sugiwara and H Katsume, Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol 19 (1992) 516-524
WA Zoghbi, RN Haichin and MA Quinones, Mid-cavity obstruction in apical hypertrophy: Doppler evidence of diastolic intraventricular gradient with higher apical pressure. Am Heart J 116 (1988) 1469-1474
S Fighali, Z Krajcer, S Edelman and RD Leachman, Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: high incidence in patients with midventricular obstruction. J Am Coll Cardiol 9 (1987) 288-294
HG Klues, WC Roberts and BJ Maron, Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 84 (1991) 1188-1197
RA Nishimura, JM Trusty, DL Hayes, DM Ilstrup, DR Larson, SN Hayes, TG Allison and AJ Tajik, Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double blind, crossover trial. J Am Coll Cardiol 29 (1997) 435-441
BJ Maron, RG Hauser and WC Roberts, Hypertrophic cardiomyopathy with left ventricular apical diverticulum. Am J Cardiol 77 (1996) 1263-1265
H Watanabe, S Kibira, T Saito, H Shimizu, T Abe, I Nakajima, K Iino and M Miura, Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J 66 (2002) 981-984
BJ Maron, Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgement?. J Am Coll Cardiol 27 (1996) 431-432
H Seggewiss and L Faber, Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr 1 (2000) 277-280
A Sheikhzadeh, B Eslami, U Stierle, AF Langbehn and KW Diederich, Midventricular obstruction-a form of hypertrophic obstructive cardiomyopathy and systolic anterior motion of the mitral valve. Clin Cardiol 9 (1986) 607-613
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tengiz, I., Ercan, E. & Türk, U.O. Percutaneous Myocardial Ablation for Left Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy. Int J Cardiovasc Imaging 22, 13–18 (2006). https://doi.org/10.1007/s10554-005-5295-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-005-5295-8